Therapeutic implications of immunohistochemical expression pattern of the cancer stem cell marker (nestin) in basal and squamous cell carcinomas

Dermatol Ther. 2020 Nov;33(6):e13921. doi: 10.1111/dth.13921. Epub 2020 Aug 5.

Abstract

Cancer stem cells (CSC) are populations of cells responsible for tumor initiation, progression and therapeutic resistance in many cancers. In the present study, we aimed to investigate the expression pattern and clinical significance of the stem cell marker nestin, in Squaous cell carcinoma (SCC) and basal cell carcinoma (BCC). The samples (23 cases of BCC and 22 cases of SCC) were immunohistochemically examined for the expression of nestin and its correlation with the corresponding clinical and pathological parameters. Nestin was expressed in four out of the 23 cases of BCC (17.4%) and was expressed in 10 out of the 22 cases of SCC (45.5%). Nestin expression between the two tumors was statistically significant (P = .042). Although a direct relationship was found between the tumor grade and nestin expression, the results were statistically insignificant (P = .495). The results of this study suggest that BCC and SCC may share some cellular origin but with different biologic behavior. The relation of nestin expression to the grade of SCC, although statistically insignificant, may suggest its role in predicting the biologic behavior of this tumor.

Keywords: basal cell carcinoma; nestin; squamous cell carcinoma; tumor marker.

MeSH terms

  • Carcinoma, Basal Cell*
  • Carcinoma, Squamous Cell*
  • Humans
  • Neoplastic Stem Cells
  • Nestin / genetics
  • Skin Neoplasms* / genetics

Substances

  • Nestin